A population?based study of macular choroidal neovascularization using optical coherence tomography in Eastern China
- Authors:
- Published online on: May 26, 2014 https://doi.org/10.3892/etm.2014.1731
- Pages: 371-376
Abstract
Introduction
Age-related macular degeneration (AMD) is a disease of the ocular fundus characterized by the degeneration of the choroidal capillaries, retinal pigment epithelium (RPE) and neural retina. AMD is the leading cause of blindness in older adults (>50 years-old) in Western countries (1). With living standards improving in China, the incidence of AMD is also increasing.
Traditionally, AMD may be classified into dry and wet forms by physicians. The dry form, or central geographic atrophy, accounts for 15–20% of AMD cases, where vision loss is ultimately caused by the loss of photoreceptors. Wet AMD, also known as neovascular or exudative AMD, results from choroidal neovascularization (CNV) and affects 80–85% of those with AMD. The wet form causes the more severe loss of vision. In the natural course of the disease, 10–20% of dry AMD cases become wet AMD cases, and 42% of patients with monocular wet AMD develop binocular wet AMD within five years (2).
Recently, a large-scale epidemiological study (n=100,000) undertaken in Shanghai First People’s Hospital (Shanghai, China) reported that the prevalence of AMD in individuals aged >45 years was 16%; wet AMD alone was 15% (3). AMD is the most common manifestation of CNV, and CNV usually leads to repeated macular bleeding, exudation and scarring, seriously damaging central visual acuity. As a result, investigation into the pathogenesis of AMD is urgently required and important for the prevention or delaying of AMD progression (4–7).
The present study included an epidemiological survey of ocular diseases in an adult population (>45 years old) in Youyi Road Community, Baoshan District, Shanghai, China, conducted to determine the prevalence of AMD in the region. For this purpose, routine ocular examinations were utilized, namely fundus photography, fundus fluorescein angiography (FFA) and ocular optical coherence tomography (OCT). Patients found to have early and intermediate-stage AMD were further recruited for follow-up observation. In these patients, the clinical and imaging characteristics of various stages of AMD were investigated, as well as the CNV characteristics of different etiologies. The present study aimed to further the understanding of the pathomorphological and functional variations of CNV in AMD patients, and optimize the guidance for the treatment of AMD.
Materials and methods
Subject recruitment
The study was a prospective, population-based study investigating the pathomorphological and functional variations of CNV in AMD patients in a Chinese population. In total, 1,813 adult citizens aged >45 years were recruited through probability sampling from Youyi Road Community, Baoshan District, Shanghai, China between April 2005 and June 2005 for an epidemiological survey. All the participants provided written informed consent. The study was approved by the local Ethics Committee of Shuguang Hospital (Baoshan branch, Shanghai, China) and was conducted in accordance with the Declaration of Helsinki.
Ocular examination
All the participants underwent a preliminary assessment of near and far visual acuity, slit-lamp biomicroscopy and a dilated fundus examination with direct ophthalmoscopy and a 90D handheld lens. For those subjects with suspected early and mid-stage AMD, further ocular examinations, including fundus photography, FFA and fast macular map and line scans using OCT, were performed. The best corrected visual acuity was assessed monocularly with linear logMAR charts, if the subject had an uncorrected visual acuity of <1.0 (less than 20/20 vision). Pupillary dilation was induced with three cycles of 0.5% tropicamide (one drop per eye), administered 5 min apart. Fundus photography, FFA and OCT were performed synchronously using a Zeiss-Stratus OCT Model 3000 and an FF450 IR fundus camera (Carl Zeiss AG, Oberkochen, Germany).
According to the size and the number of drusens under the retina, dry AMD may be further classified into three stages: Early, intermediate and advanced stages (8). Dry AMD is the most common form of AMD in the early or intermediate stages. Early AMD was defined as the presence of coexisting multiple small drusens (diameter, <63 μm) and a few medium-sized drusens (63–124 μm) in the macular area. The presence of widespread medium-sized drusens and at least one drusen of >125 μm defined intermediate AMD. Advanced AMD was indicated by the presence of either geographic atrophy involving the fovea or exudative detachment induced by CNV. The subjects with early and intermediate-stage AMD were included in the present study. Subjects were excluded from the study if the FFA results were negative, fundus visibility was poor due to lens opacity or other reasons or if the patient had a history of central chorioretinitis or macular degeneration (which is difficult to distinguish from AMD). A trained technician performed all the scanning sessions.
Follow-up
Subjects with early and intermediate-stage AMD were reviewed one year following the initial examination. Thereafter, the patients were reviewed for 6–24 months depending on the stage of AMD. Mean follow-up duration ranged from 18 to 24 months while the interval of follow-up of each patient ranged from 6–18 months. During the follow-up period, the following ocular examinations were performed: Best corrected visual acuity, anterior segment analysis by a slit-lamp, dilated fundus evaluation by direct ophthalmoscopy and a 90D handheld lens, fundus photography, FFA and OCT. Patients with angiogenesis or geographic atrophy were administered the appropriate drug treatment and were withdrawn from the study.
ICGA was performed using Carl Zeiss FF-450-IR Fundus Retinal Eye Medical Ophthalmic Camera System, 30° and 50° macular CF and indocyanine green ICG 25 mg (LiaoYang No. 3 Pharmaceutical factory, LiaoYang, China). After allergic test, rapid intravenous elbow injection of ICG was performed within 5 sec. ICGA observation duration was 30 min or more in total after injection in which the early stage was within 5 min, 10 to 20 min as a medium stage, and after 20 min as late stage of angiography. The results were analyzed by two ophthalmologists independently.
Statistical analysis
All data are expressed as the mean ± standard error of the mean. Intergroup comparisons were conducted with the χ2 test using the SigmaStat-integrated SigmaPlot statistical software package (V 12.0; SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference for all the analyses.
Results
Patient characteristics
A total of 1,813 subjects were initially enrolled, however, only 1,619 individuals (89.3%) completed the study. Participants included workers with a number of professions, including manual labor, peasants, teachers and civil servants. The majority of the patients belonged to China’s main ethnic group (Han Chinese). The enrolled 1,813 subjects comprised 829 females (45.65%) and 987 males (54.35%), ranging in age between 45 and 82 years.
AMD diagnosis
Among the 1,619 subjects who completed the study, 59 patients (3.64%, 70 eyes) were diagnosed as early and intermediate-stage AMD, while 42 patients (2.59%, 45 eyes) were diagnosed with advanced AMD. Exudative (wet) AMD (including macular disciform scars) was identified in nine subjects (10 eyes), which was 0.56% of those who completed the study and 21.4% of advanced AMD patients. Atrophic (dry) AMD was found in 33 cases (35 eyes), which was 2.04% of the final number of patients enrolled and 78.57% of advanced AMD patients.
Combined FFA and OCT examination provided the highest detection rate of AMD for early and intermediate-stage AMD patients, which was significantly better than the detection rates when the techniques were performed alone (all P<0.05; Tables I and II).
Follow-up observations
In total, 59 early and intermediate-stage AMD patients were followed-up for 18–54 months (mean follow-up time, 38.6±11.3 months) and all underwent complete ocular examinations during this time. Five eyes (3.62%) developed into geographic atrophy 56 months after the initial recruitment examination (mean duration, 43.6±9.3 months; Fig. 1). A total of four eyes (2.9%) developed into exudative AMD between 22 and 37 months following the initial examination (mean duration, 21.2±12.8 months; Fig. 2). Calcific drusens were absorbed in one eye (0.72%) 33 months following the initial recruitment examination (Fig. 3). In 40 eyes (56.5%), increased or fused drusens were observed between 44 and 60 months subsequent to the initial recruitment examination (mean duration, 47.6±10.5 months; Fig. 4).
Discussion
As China becomes an aging society, the prevalence of age-related diseases has significantly increased. AMD is one of the leading causes of blindness and poor vision, resulting in an inability to work or live independently, which adds a heavy burden on the individual, the family and society. Since macular damage is irreversible, early detection and timely treatment are important in preventing the enlargement and coalescence of drusens and early CNV, thereby reducing or delaying visual impairment and improving the patients’ quality of life (9–12).
An epidemiological survey of AMD in Youyi Road Community, Baoshan District, Shanghai, China was performed between April 2005 and June 2005. Individuals with early and intermediate-stage AMD were selected to investigate the pathomorphological and functional variations of CNV in AMD patients in a Chinese population. The natural course of AMD was satisfactorily observed and recorded using OCT combined with FFA. FFA is useful for assessing the range of RPE damage, while OCT can quantify the thickness of the neurosensory retina and detect traces of subretinal fluid and early thinning of the neural cortex in atrophic AMD. In addition, OCT can be used to determine the degree of damage to the photoreceptors, Bruch’s membrane and the choriocapillary layer (CCL) (13).
The clinical staging criteria of the Age-Related Eye Disease Study do not include a clear definition of vision. It is increasingly recognized that patients with early and intermediate-stage AMD without macular involvement can usually maintain good eyesight. Furthermore, visual impairment is usually gradual and severity varies with the lesion site. As a result, classification of AMD is less meaningful if stages of its pathogenesis are based on vision. Thus, we hypothesize that it is more practical in clinical practice to base the severity of AMD on the fundus phenotype as viewed by OCT and FFA, rather than declined vision.
OCT and FFA were combined to diagnose and follow-up patients with early and intermediate-stage AMD, focusing on the organic and functional changes observed in the macular area of the photoreceptors, RPE and CCL. Detection via combined OCT and FFA provides a more accurate and objective assessment of AMD damage. Fundus photography revealed that there were two eyes (2.9%) that developed exudative changes, including unclear drusen borders and proliferating pigments, among the 59 patients (70 eyes) with early and intermediate-stage AMD that were followed-up for 18–54 months. The aforementioned cases presented with central blocked fluorescence in the center of the drusens, fuzzy weak fluorescence around the drusens and mild enhanced fluorescence in advanced stages of FFA imaging. As exudative changes advanced, the original drusens became obscure and large areas of subretinal or subpigmental hemorrhages appeared in the fundus images. In addition, the bleeding site was blocked, fluorescein leakage had occurred due to neovascularization and fluorescence accumulation in cavities of pigment epithelial detachment and neurosensory retinal detachment were observed through FFA. OCT showed wide range of dome bands within the RPE/CCL area (14,15). When geographic atrophy occurred, RPE serous detachment in the macular area, over a range of one pupillary distance, was observed in the fundus images, FFA and OCT scans. During the follow-up, RPE detachment was gradually absorbed, the pigments were deposited and eventually the photoreceptors, RPE and choroidal capillaries became thinner.
In conclusion, FFA is a valuable tool for making a definitive diagnosis of AMD, however, the invasiveness of the procedure limits the usage on a single patient. OCT is a noninvasive test that can provide an in vivo, objective and precise measurement of macular and retinal nerve fiber layer thickness. OCT has become popular and is used widely in clinical practice worldwide. The advantages and characteristics of this technique have been thoroughly described previously (16–18). OCT enables ophthalmologists to diagnose retinal diseases by detecting small changes in retinal and macular morphology, including the thickness and volume. As a result, OCT is an easier and more comfortable method to follow-up patients with early and intermediate-stage AMD, and the facilitation of OCT in the diagnosis of retinal diseases contributes to a positive significance in clinical practice.
Acknowledgements
The study was supported by grants from the Projects of Shanghai Municipal Health Bureau Key Specialty Construction (no. ZK2012A03), the Science and Technology Commission of Baoshan District, Shanghai (no. 08-E-6) and the Integrative Medicine Hospital Key Specialty Construction of Baoshan District, Shanghai (no. ZXYZK2012A03).
References
Stevens GA, White RA, Flaxman SR, et al; Vision Loss Expert Group. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology. 120:2377–2384. 2013. | |
de Jong PT: Age-related macular degeneration. N Engl J Med. 355:1474–1485. 2006. | |
Zou H, Zhang X, Xu X and He Z: Epidemiology survey of rhegmatogenous retinal detachment in Beijing districts, Shanghai. Zhonghua Yan Ke Za Zhi. 38:580–583. 2002.(In Chinese). | |
Klein R, Klein BE, Tomany SC, Meuer SM and Huang GH: Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology. 109:1767–1779. 2002. | |
Friedman DS, O’Colmain BJ, Muñoz B, et al; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 122:564–572. 2004. View Article : Google Scholar : PubMed/NCBI | |
Seddon JM, Ajani UA, Sperduto RD, et al: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 272:1413–1420. 1994. View Article : Google Scholar : PubMed/NCBI | |
Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W and Mitchell P: Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 115:334–341. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ferris FL, Davis MD, Clemons TE, et al; Age-related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No 18. Arch Ophthalmol. 123:1570–1574. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fung AE, Lalwani GA, Rosenfeld PJ, et al: An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 143:566–583. 2007. View Article : Google Scholar | |
Lalwani GA, Rosenfeld PJ, Fung AE, et al: A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 148:43–58. 2009.PubMed/NCBI | |
Funk M, Karl D, Georgopoulos M, et al: Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology. 116:2393–2399. 2009. View Article : Google Scholar : PubMed/NCBI | |
Gass JD: Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 118:285–298. 1994. View Article : Google Scholar | |
Petrarca R, Dugel PU, Nau J, Slakter JS, Jaffe GJ and Jackson TL: Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): Month 12 optical coherence tomography and fluorescein angiography. Ophthalmology. 120:328–333. 2013. View Article : Google Scholar | |
Souied EH, Delcourt C, Querques G, et al: Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. Ophthalmology. 120:1619–1631. 2013. View Article : Google Scholar : PubMed/NCBI | |
Morrison MA, Silveira AC, Huynh N, et al: Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 5:538–568. 2011. View Article : Google Scholar : PubMed/NCBI | |
Paunescu LA, Schuman JS, Price LL, et al: Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci. 45:1716–1724. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hess DB, Asrani SG, Bhide MG, Enyedi LB, Stinnett SS and Freedman SF: Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography. Am J Ophthalmol. 139:509–517. 2005. View Article : Google Scholar : PubMed/NCBI | |
Medeiros FA, Zangwill LM, Bowd C and Weinreb RN: Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol. 122:827–837. 2004. View Article : Google Scholar : PubMed/NCBI |